StockData
Serina Therapeutics, Inc. logo

Serina Therapeutics, Inc. (SER) income statement

SERNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 2/30
$1.20−0.15 (-11.11%)

Close on Nov 19, 2026Market cap $30.48MP/E –Yield –

See a number that looks wrong?